Differential in vivo activity of docetaxel plus PS-341 combination therapy in non-small cell lung carcinoma (NSCLC) xenografts.

被引：0
作者：
Gumerlock, PH [1 ]
Kimura, T [1 ]
Holland, WS [1 ]
Shih, CDD [1 ]
Lara, PN [1 ]
Gandara, DR [1 ]
机构：
[1] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7144
引用
收藏
页码：652S / 652S
页数：1
相关论文
共 50 条
  • [41] Combination chemotherapy with docetaxel and carboplatin for advanced non-small cell lung cancer
    Schuette, W
    Bork, I
    Wollschläger, B
    Schädlich, S
    CLINICAL DRUG INVESTIGATION, 2001, 21 (03) : 161 - 168
  • [42] Microwave ablation plus camrelizumab monotherapy or combination therapy in non-small cell lung cancer
    Huang, Yahan
    Wang, Jiao
    Hu, Yanting
    Cao, Pikun
    Wang, Gang
    Cai, Hongchao
    Wang, Meixiang
    Yang, Xia
    Wei, Zhigang
    Ye, Xin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [43] Safety of Necitumumab and Abemaciclib Combination Therapy in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
    Besse, Benjamin
    Vansteenkiste, Johan
    Renault, Patrick-Aldo
    Frimodt-Moller, Bente
    Chao, Grace
    Gil, Maciej
    Barlesi, Fabrice
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1227 - S1228
  • [44] Combination therapy with gefitinib and fulvestrant (G/F) for women with non-small cell lung cancer (NSCLC)
    Dubey, S
    Siegfried, J
    Stabile, L
    Kolesar, J
    Belani, C
    Hoang, T
    Eickhoff, J
    Marcotte, S
    Schiller, J
    Traynor, A
    LUNG CANCER, 2005, 49 : S87 - S88
  • [45] Combination therapy with gefitinib and fulvestrant (G/F) for women with non-small cell lung cancer (NSCLC).
    Traynor, AM
    Schiller, JH
    Stabile, LP
    Kolesar, JM
    Belani, CP
    Hoang, T
    Dubey, S
    Eickhoff, J
    Marcotte, SM
    Siegfried, JM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 676S - 676S
  • [46] Vaccines as adjuvant therapy for non-small cell lung cancer (NSCLC)
    Butts, Charles
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S220 - S221
  • [47] STATUS OF IMMUNE THERAPY IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Parums, D. V.
    DRUGS OF THE FUTURE, 2014, 39 (07) : 469 - 477
  • [48] Cobolimab with Dostarlimab and Docetaxel in Patients with Advanced Non-small Cell Lung Cancer (NSCLC): COSTAR Lung
    Kim, H. R.
    Gridelli, C.
    Kapur, D.
    Tufman, A.
    Felip, E.
    Velcheti, V.
    Kim, Y. J.
    Goetze, T. O.
    Lopez, P. Garrido
    Corre, R.
    Penkov, K.
    Anjum, R.
    Di Pace, B.
    Liu, W.
    Borgovan, T.
    Ledger, D.
    Carver, J.
    Waszak, A.
    Dhar, A.
    Novello, S.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S109 - S110
  • [49] Combination therapy with gemcitabine in non-small cell lung cancer
    Mosconi, AM
    Crino, L
    Tonato, M
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : S14 - S17
  • [50] Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma: a multicentre phase I study
    Giannakakis, T
    Ziras, N
    Kakolyris, S
    Mavroudis, D
    Androulakis, N
    Agelaki, S
    Parashos, M
    Sarra, E
    Dimou, T
    Hatzidaki, D
    Vlachonikolis, J
    Georgoulias, V
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (06) : 742 - 747
12345